Cita APA

Custódio, P. R., Colombo, J., Ventura, F. V., Castro, T. B., & Zuccari, D. A. P. C. [. (2020). Melatonin treatment combined with TGF-β silencing inhibits epithelialmesenchymal transition in CF41 canine mammary cancer cell line.

Citación estilo Chicago

Custódio, Paulo R., Jucimara Colombo, Fabrício V. Ventura, Tialfi B. Castro, y Debora A. P. C. [UNESP] Zuccari. Melatonin Treatment Combined With TGF-β Silencing Inhibits Epithelialmesenchymal Transition in CF41 Canine Mammary Cancer Cell Line. 2020.

Cita MLA

Custódio, Paulo R., et al. Melatonin Treatment Combined With TGF-β Silencing Inhibits Epithelialmesenchymal Transition in CF41 Canine Mammary Cancer Cell Line. 2020.